GlassScriptPhysician profile
Ada I Vera
NPI 1902942725
$5,211.25
in general payments reported to CMS, 2019-2025
28 companies · $1,204 in 2025
The $1,204 reported for 2025 was more than what 83% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $537 · 2021: $528 · 2022: $1,028 · 2023: $383 · 2024: $987 · 2025: $1,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,574.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,797.16 | 2019-2025 | Collagenase Santyl, Grafix Pl, Regranex |
| Kerecis Limited | $530.40 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Paratek Pharmaceuticals, INC. | $452.02 | 2019-2025 | Nuzyra |
| Mimedx Group, INC. | $411.27 | 2024-2025 | |
| Tactile Systems Technology INC | $373.86 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Bioventus LLC | $255.83 | 2021-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Lifenet Health | $225.43 | 2025 | Theragenesis Wound Matrix |
| Koya Medical, INC. | $160.85 | 2024 | Dayspring, Koya Medical |
| Melinta Therapeutics, LLC | $160.80 | 2019-2021 | |
| Abbvie INC. | $129.02 | 2022-2025 | |
| Urgo Medical North America, LLC | $126.32 | 2022-2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Convatec INC. | $102.02 | 2021-2023 | |
| Organogenesis INC. | $80.58 | 2021-2025 | Puraply Wound Matrix, Puraply Am |
| Solventum Corporation | $70.49 | 2025 | Activ.A.C. |
| Zyla Life Sciences, INC. | $37.00 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $36.81 | 2019-2020 | |
| Next Science LLC | $36.46 | 2022-2023 | Xperience, Blastx, Surgx |
| Mayne Pharma Commercial LLC | $34.61 | 2021 | |
| Polarityte, INC. | $32.15 | 2020 | |
| Sandoz INC. | $23.40 | 2019 | |
| Ovik Health, LLC | $19.46 | 2019 | |
| Ossur Americas, INC. | $19.20 | 2025 | |
| Innovation Technologies INC | $18.43 | 2024 | Irrisept |
| Bsn Medical INC | $17.53 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.03 | 2022 | |
| Merck Sharp & Dohme LLC | $15.08 | 2019 | |
| Forte Bio-Pharma LLC | $14.87 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ada Vera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.